Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Quattro74on Feb 29, 2020 6:36pm
97 Views
Post# 30751854

RE:RE:RE:New Paper by Drs. Lilge and Betz

RE:RE:RE:New Paper by Drs. Lilge and Betz
Hempdoc wrote:
Quattro74 wrote:
Hopefully Dr. Lilge can pull this off, hours > minutes. And for multiple indications. Sure would speed up wider adoption of our PDT ACT if this could be rolled out prior to end of Phase 2 NMIBC.

 


 

 

Let's hope...although I see the widest/quickest adoption of our ACT (TLD 1433) happening without the need for PDT....at least for some indications.

I'm hoping TLT perfects the use of a simple x-ray or perhaps a low-dose form of stereotactic radiotherapy to do the same job as PDT, & hence eliminate the need for any additional invasive procedure & its concomitant anesthetic/procedural risk.  Pre & post surgical resection patients (for lung, brain or any deep-seated tumor) would surely be grateful...the ease, convenience & safety of such an approach would draw significant interest from both patients & doctors...JMO.



Interesting Doc, 

Still laughing bout the Cervix joke, so what do you think about TLT's CLT cancer pre-treatment? Would love to see them try to roll that out also. While we're thinking about other inds.
Bullboard Posts